Announcements Trials
Browse Landscape

Status

Recruiting 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 2

Sponsor

Conditions

Breast Neoplasms 2360Neoplasms 1709Prostatic Neoplasms 1201Lung Neoplasms 926Colorectal Neoplasms 886Carcinoma, Non-Small-Cell Lung 869Leukemia, Myeloid, Acute 593Pancreatic Neoplasms 578Multiple Myeloma 551Carcinoma, Hepatocellular 518Brain Neoplasms 516Neoplasm Metastasis 462Head and Neck Neoplasms 458Melanoma 417Ovarian Neoplasms 414Glioblastoma 403Precursor Cell Lymphoblastic Leukemia-Lymphoma 400Stomach Neoplasms 377Uterine Cervical Neoplasms 365Squamous Cell Carcinoma of Head and Neck 362Rectal Neoplasms 342Recurrence 337Sarcoma 327Hematologic Neoplasms 324Colonic Neoplasms 323Lymphoma 321Triple Negative Breast Neoplasms 291Carcinoma, Renal Cell 284Glioma 283Urinary Bladder Neoplasms 281

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Drug Resistant Epilepsy × 1 year × Clear all
NCT06724029 2026-03-30

NEON

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Recruiting
4,500 enrolled

Drug Resistant Epilepsy, Aneurysm, Arteriovenous Malformations, Depression, Facial Pain, Hematoma, Subdural, Hydrocephalus, Hydrocephalus, Normal Pressure, Moyamoya Disease, Muscle Spasticity, Neuralgia, Obsessive-Compulsive Disorder, Subarachnoid Hemorrhage, Tremor, Trigeminal Neuralgia, Dystonic Disorders, Hematoma, Epidural, Spinal

NCT05469373 2025-12-23

ESIS in Pediatric DRE

Children's Hospital Medical Center, Cincinnati

Recruiting
86 enrolled

Drug Resistant Epilepsy, Epilepsy, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡